These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28579491)

  • 1. Recommendation to reconsider examining cannabis subtypes together due to opposing effects on brain, cognition and behavior.
    Rømer Thomsen K; Callesen MB; Feldstein Ewing SW
    Neurosci Biobehav Rev; 2017 Sep; 80():156-158. PubMed ID: 28579491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ
    Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition.
    Colizzi M; Bhattacharyya S
    Curr Addict Rep; 2017; 4(2):62-74. PubMed ID: 28580227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
    Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia.
    Osborne AL; Solowij N; Weston-Green K
    Neurosci Biobehav Rev; 2017 Jan; 72():310-324. PubMed ID: 27884751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia.
    Arnold JC; Boucher AA; Karl T
    Curr Pharm Des; 2012; 18(32):5113-30. PubMed ID: 22716133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
    Kayir H; Ruffolo J; McCunn P; Khokhar JY
    Curr Top Behav Neurosci; 2023; 63():437-461. PubMed ID: 36318403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
    Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
    J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Adolescent Δ
    Murphy M; Mills S; Winstone J; Leishman E; Wager-Miller J; Bradshaw H; Mackie K
    Cannabis Cannabinoid Res; 2017; 2(1):235-246. PubMed ID: 29098186
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards a better cannabis drug.
    Mechoulam R; Parker L
    Br J Pharmacol; 2013 Dec; 170(7):1363-4. PubMed ID: 24024867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
    Morgan CJ; Curran HV
    Br J Psychiatry; 2008 Apr; 192(4):306-7. PubMed ID: 18378995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
    Todd SM; Arnold JC
    Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.